# NKGEN BIOTECH INC (NKGNW)

> Institutional ownership reported to the SEC as of Q1 2025, from Form 13F filings. Source: https://holderbook.com/stocks/NKGNW/

- Reporting holders: 2
- Reported value: $14.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RIVERNORTH CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1447578-rivernorth-capital-management-llc/) | $13.1K | 652,432 | 0.0% | 6 |
| [Mint Tower Capital Management B.V.](https://holderbook.com/funds/1666606-mint-tower-capital-management-b-v/) | $1.0K | 40,000 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2025 | 2 | $14.1K |
| Q4 2024 | 27 | $270.8K |
| Q3 2024 | 30 | $161.6K |
| Q2 2024 | 32 | $226.7K |
| Q1 2024 | 32 | $353.9K |
| Q4 2023 | 33 | $202.3K |
| Q3 2023 | 1 | $37.2K |